The estimated Net Worth of Jeffrey C Hunt is at least 7.01 百万$ dollars as of 4 November 2013. Jeffrey Hunt owns over 7,883 units of West Pharmaceutical Services stock worth over 7,007,264$ and over the last 14 years Jeffrey sold WST stock worth over 0$.
Jeffrey has made over 4 trades of the West Pharmaceutical Services stock since 2012, according to the Form 4 filled with the SEC. Most recently Jeffrey exercised 7,883 units of WST stock worth 167,277$ on 4 November 2013.
The largest trade Jeffrey's ever made was exercising 12,012 units of West Pharmaceutical Services stock on 23 November 2012 worth over 233,153$. On average, Jeffrey trades about 2,636 units every 41 days since 2011. As of 4 November 2013 Jeffrey still owns at least 23,176 units of West Pharmaceutical Services stock.
You can see the complete history of Jeffrey Hunt stock trades at the bottom of the page.
Jeffrey's mailing address filed with the SEC is 101 GORDON DRIVE, , LIONVILLE, PA, 19341.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over 32,829,857$ worth of West Pharmaceutical Services stock and bought 19,924 units worth 1,139,950$ . The most active insiders traders include Robert F Friel、Paolo Pucci、Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of 4,786,805$. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth 308,700$.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: